Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

XENE

Xenon Pharmaceuticals Inc

May 08 • 04:00PM ET

56.44

+0.44 0.79 %

Healthcare • Biotechnology • Canada • Mid • NASD

Peers: AXSM BHVN ALKS ACAD NBIX

| Held by: IWM IWO IBB VTWO SPDW SBIO VTWG VT NUSC ESML

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-4.70	Insider Own	2.88%	Shs Outstand	96.62M	Perf Week	0.55%
Market Cap	5.39B	Forward P/E	-	EPS next Y	-4.81	Insider Trans	-11.64%	Shs Float	92.68M	Perf Month	-3.67%
Enterprise Value	4.30B	PEG	-	EPS next Q	-1.13	Inst Own	86.68%	Short Float	5.24%	Perf Quarter	36.39%
Income	-383.17M	P/S	-	EPS this Y	-8.26%	Inst Trans	0.26%	Short Ratio	3.47	Perf Half Y	45.99%
Sales	0.00M	P/B	4.08	EPS next Y	-1.87%	ROA	-35.98%	Short Interest	4.85M	Perf YTD	25.93%
Book/sh	13.85	P/C	4.92	EPS next 5Y	10.92%	ROE	-37.53%	52W High	63.95 -11.74%	Perf Year	58.81%
Cash/sh	11.47	P/FCF	-	EPS past 3/5Y	-28.36% -40.02%	ROIC	-28.51%	52W Low	28.19 100.21%	Perf 3Y	32.80%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-7.36% -25.26%	Gross Margin	-	Volatility	3.48% 3.31%	Perf 5Y	204.92%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-46.29%	Oper. Margin	-	ATR (14)	2.04	Perf 10Y	743.65%
Dividend Ex-Date	-	Quick Ratio	27.79	Sales Y/Y TTM	-100.00%	Profit Margin	-	RSI (14)	51.07	Recom	1.05
Dividend Gr. 3/5Y	- -	Current Ratio	27.79	EPS Q/Q	-41.69%	SMA20	-0.86%	Beta	0.65	Target Price	80.30
Payout	-	Debt/Eq	0.01	Sales Q/Q	-100.00%	SMA50	2.42%	Rel Volume	0.65	Prev Close	56.00
Employees	370	LT Debt/Eq	0.00	Earnings	May 07 AMC	SMA200	28.56%	Avg Volume	1.40M	Price	56.44
IPO	Nov 05, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	0.81% -100.00%	Trades		Volume	902,288	Change	0.79%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)